News | July 06, 2008

Cancer Center First to Fire Up Varian's New RT System

July 7, 2008 - The Center for Radiation Therapy of Beverly Hills became the first medical center in California to commence treating cancer patients with a new technique utilizing RapidArc radiotherapy technology from Varian Medical Systems.

RapidArc delivers image-guided, intensity-modulated radiation therapy (IMRT) treatment reportedly two to eight times faster than is possible with conventional IMRT or helical tomotherapy.

Prior to each treatment, special imaging technology is used to pinpoint the targeted tumor and line it up so that the radiation is delivered precisely and accurately. Once the patient is properly positioned, the actual treatments are said to be typically delivered in less than two minutes with just a single 360-degree rotation of the treatment machine around the patient.

A 77-year-old man with glioblastoma multiforme, a form of brain cancer, was the first to receive a two-minute RapidArc treatment at the center. "This patient was an ideal candidate, because RapidArc targets cancerous regions and limits the amount of dose reaching the surrounding healthy tissues," said Henry Yampolsky, M.D., radiation oncologist. "We always want to avoid hitting healthy tissues, and that was especially important for this particular patient because the tumor is very close to the optic chiasm and brainstem-two critical areas that need to be protected."

In addition, Dr. Yampolsky said that his patient is extremely claustrophobic and has a fear of lying flat, so conventional treatments, which take up to 20 minutes, have been hard for him to tolerate. "Using RapidArc, we were able to complete the treatment in less than four minutes, significantly reducing the amount of time that the patient had to spend on the table."

For more information: www.varian.com

Related Content

Proton Therapy Lowers Risk of Side Effects Compared to Conventional Radiation
News | Proton Therapy | May 23, 2019
Cancer patients getting proton therapy instead of traditional photon radiation are at a significantly lower risk of...
Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carrie Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Henry Ford Hospital's ViewRay MRIdian linear accelerator system allows real-time MRI-guided radiotherapy. Shown is the support staff for this system. In the center of the photo is Benjamin Movsas, M.D., chair of radiation oncology at Henry Ford Cancer Institute. Second from the right is Carri Glide-Hurst, Ph.D., director of translational research, radiation oncology.

Feature | Henry Ford Hospital | May 21, 2019 | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the radiation oncology and radiology conferences about new res
Varian Acquiring Cancer Treatment Services International
News | Radiation Therapy | May 21, 2019
Varian Medical Systems announced it has entered into a definitive agreement to acquire India’s Cancer Treatment...
Videos | Radiation Therapy | May 21, 2019
This is a walk through of the ViewRay MRIdian MRI-guided radiotherapy system installed at ...
Partial Breast Irradiation Effective, Convenient Treatment Option for Low-Risk Breast Cancer
News | Radiation Therapy | May 20, 2019
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast...
New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...